Ureteral Stent Market Report
First published: 20 October 2024 | Last updated: 28 May 2026 | Report Code: ureteral-stent
Ureteral Stent Market — USD 1.5 billion in 2023, Growing to USD 2.95B by 2033 at 6.8% CAGR
This report covers the comprehensive analysis of the Ureteral Stent market, encompassing market size, growth forecasts, key trends, and regional insights from 2023 to 2033.
Key Takeaways
- Global market value increases from $1.50 Billion in 2023 to $2.95 Billion in 2033, driven by rising procedure volumes and device innovation.
- The forecast period 2023 to 2033 reflects a 6.8% CAGR as minimally invasive interventions and patient awareness expand use.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Material and product diversity—silicone, polyurethane, metal; double-J, single-J, pigtail—underpins clinical adoption across hospitals and outpatient settings.
- Key manufacturers include Boston Scientific Corporation, Bard Medical, Cook Medical, and Coloplast A/S, shaping product development and distribution strategies.
Ureteral Stent Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The Ureteral Stent Market Report examines a sector valued at $1.50 Billion in 2023 with projected expansion to $2.95 Billion by 2033 at a 6.8% CAGR. Growth is propelled by increasing incidence of urinary tract obstructions, higher rates of endourological procedures, and ongoing product innovation such as improved materials and designs. The report dissects market segmentation across product type, material, application, end-user, and distribution channel, and evaluates regional performance where North America represents the largest market. Competitive dynamics are characterized by established medical device companies—Boston Scientific Corporation, Bard Medical, Cook Medical, and Coloplast A/S—focusing on clinical evidence, reimbursement navigation, and expanded distribution. Regulatory complexity and potential post-implantation complications remain constraints that vendors must address through safety data, clinician education, and collaboration with healthcare providers. The analysis offers actionable insights for stakeholders targeting hospitals, ambulatory surgical centers, and specialty clinics, while spotlighting opportunities created by minimally invasive techniques and patient-focused device enhancements.
Key Growth Drivers
- Rising prevalence of urinary tract disorders increases demand for stent placement and related procedures.
- Advances in stent materials and designs improve patient comfort and extend clinical applicability.
- Growth in minimally invasive urological surgeries broadens use across hospital and outpatient centers.
- Expanded clinician awareness and better diagnostic access accelerate identification and treatment of obstructions.
- Manufacturer investments in clinical evidence and distribution networks support wider adoption in key markets.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $2.95 Billion |
| Top Companies | Boston Scientific Corporation, Bard Medical, Cook Medical, Coloplast A/S |
| Published Date | 20 October 2024 |
| Last Modified Date | 28 May 2026 |
Ureteral Stent Market Overview
Customize Ureteral Stent Market Report market research report
- ✔ Get in-depth analysis of Ureteral Stent market size, growth, and forecasts.
- ✔ Understand Ureteral Stent's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Ureteral Stent
What is the Market Size & CAGR of Ureteral Stent Market Report market in 2023?
Ureteral Stent Industry Analysis
Ureteral Stent Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Ureteral Stent Market Report Market Analysis Report by Region
Europe Ureteral Stent Market Report:
Europe grows from $0.42 Billion in 2023 to $0.83 Billion in 2033. Growth is supported by growing procedural uptake, increasing clinician familiarity with minimally invasive approaches, and ongoing product development addressing patient comfort and durability.Asia Pacific Ureteral Stent Market Report:
Asia Pacific grows from $0.28 Billion in 2023 to $0.56 Billion in 2033. Expansion in this region is linked to rising healthcare access, increased urological procedure volumes, and greater market penetration by established manufacturers.North America Ureteral Stent Market Report:
North America is largest regional market, rising from $0.58 Billion in 2023 to $1.14 Billion in 2033. Local drivers include advanced clinical infrastructure, high procedure rates for obstructive urinary conditions, and active adoption of improved stent technologies by hospitals and outpatient centers.South America Ureteral Stent Market Report:
Latin America grows from $0.08 Billion in 2023 to $0.15 Billion in 2033. Regional growth is driven by gradual improvements in healthcare delivery, expanding availability of urological services, and wider distribution through direct and retail channels.Middle East & Africa Ureteral Stent Market Report:
Middle East and Africa grows from $0.13 Billion in 2023 to $0.26 Billion in 2033. Local momentum stems from investments in hospital capabilities, growing awareness of urological conditions, and adoption of established device options in major centers.Tell us your focus area and get a customized research report.
Research Methodology
Ureteral Stent Market Analysis By Product Type
The Ureteral Stent market, segmented by product type, shows double-J stents dominating with a market size of $1.00 billion in 2023, projected to reach $1.97 billion by 2033. Single-J and pigtail stents also play significant roles, focusing on various urological applications. Their uses are crucial in procedures like rigid or flexible cystoscopy transformations.
Ureteral Stent Market Analysis By Material
Silicone stents lead the material segment with a market share of 66.76%, valued at $1.00 billion in 2023, increasing at a steady pace to $1.97 billion by 2033. Polyurethane stents and metal stents are capturing niche applications, demonstrating their unique benefits, such as durability and biocompatibility.
Ureteral Stent Market Analysis By Application
The primary application area for ureteral stents is kidney stones, representing a compelling market share of 66.76%. Urethral obstruction follows closely, covering critical concerns in urology. The market is witnessing a surge in innovations that respond to these specific applications.
Ureteral Stent Market Analysis By End User
Hospitals remain the primary end-users of ureteral stents, accounting for 66.76% market share with a projected growth from $1.00 billion in 2023 to $1.97 billion in 2033. Ambulatory surgical centers and specialty clinics are significant contributors as well.
Ureteral Stent Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Ureteral Stent Industry
Boston Scientific Corporation:
A leader in the medical device field, Boston Scientific specializes in innovative urology solutions, including advanced ureteral stent technologies to enhance patient care.Bard Medical:
A subsidiary of Becton, Dickinson and Company, Bard Medical focuses on stents and other urological products, renowned for high-quality devices and extensive market reach.Cook Medical:
Cook Medical is known for its broad array of ureteral stent products, dedicated to advancing patient outcomes through innovative medical technologies.Coloplast A/S:
Specializing in urology and continence care, Coloplast provides a range of gravitation and supportive stents designed to improve patient quality of life.We're grateful to work with incredible clients.
FAQs
What is the market size of the Ureteral Stent Market Report in 2023?
The market size in 2023 is $1.50 Billion, as stated in the report's base-year data.
How big will the market be in 2033?
The projected market size for 2033 is $2.95 Billion, based on the report's forecast figures.
What is the CAGR for the forecast period 2023 to 2033?
The compound annual growth rate for 2023 to 2033 is 6.8%, according to the report's projections.
Is there a single fastest Growing region in the Ureteral Stent Market Report market?
No single fastest-growing region is stated for the Ureteral Stent Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which product types are included in the segmentation?
Product segmentation includes double-J stents, single-J stents, and pigtail stents, covering common clinical variants.
Who are the leading companies in this market?
Top companies listed in the report are Boston Scientific Corporation, Bard Medical, Cook Medical, and Coloplast A/S.
What end Users drive demand for ureteral stents?
Primary end-users comprise hospitals, ambulatory surgical centers, and specialty clinics, reflecting both inpatient and outpatient care settings.
How big is the Europe market in 2023 and 2033?
Europe is reported at $0.42 Billion in 2023 and grows to $0.83 Billion by 2033, per the regional figures provided.
What factors limit market expansion?
Regulatory requirements and potential post-procedure complications present constraints that require clinical evidence and provider education.
Which distribution channels are covered?
Distribution channels include direct sales, online sales, and retail pharmacies as specified in the report's segmentation.